Publications

5491 Results

NCCN Guidelines® Insights: Survivorship, Version 1.2022

Authors
T Sanft;A Day;L Peterson;MA Rodriguez;S Ansbaugh;S Armenian;K Baker;T Ballinger;G Broderick;W Denmark-Wahnefried;K Dickinson;N Fairman;D Friedman;M Goldman;NL Henry;C Hill-Kayser;M Hudson;N Khakpour;D Koura;A McDonough;M Melisko;K Mooney;HCF Moore;N Moryl;H Neuman;T O'Connor;L Overholser;E Paskett;C Patel;W Pirl;A Porpiglia;K Ruddy;L Schapira;L Shockney;S Smith;K Syrjala;A Tevaarwerk;E Yang;P Zee;N McMillian;D Freedman-Cass
Journal / Conference
Journal of the Comprehensive Cancer Network Oct;20(10):1080-1090
Year
2022
Research Committee(s)
Cancer Survivorship
PMID
PMID36240847

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134)

Authors
R Jensen;Y Zheng;M Atkins;M Atkins;B Chmielowski;A Tarhini;T Truong;D Davar;M O'Rourke;B Curti;J Brell;K Kendra;A Ikeguchi;S Lee;A Potosky;J Wolchok;A Ribas;J Kirkwood;L Wagner;D Cella
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 9559); American Society of Clinical Oncology
Year
2022
Research Committee(s)
Melanoma
Study Number(s)
CTSU/EA6134

A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)

Authors
R McKay;H Jacene;P Atherton;V Marcotte;A Ajmera;S Baghaie;J Koball;T Zemla;R Chen;A Choudhury;J Lang;S Cole;M Parikh;T Al Baghdadi;Y Kwok;A Tan;H Beltran;D George;M Morris;T Choueiri
Journal / Conference
International Kidney Cancer Symposium (November 4-5, 2022, Austin, TX), TIPS, Poster Board F1 Abstract 49
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/A031801

The Expanding Role of the Advanced Practice Provider in National Cancer Institute Sponsored Trials

Authors
C Braun-Inglis;M Bakitas;L Kottschade;B O'Brien;M Flannery;A DeTroye;A Benson;M Good;K Castro;J Myers
Journal / Conference
JADPRO Jan/Feb, Vol 14, No 1 (JADPRO Live Conference 2022 (October 20 thru 23, 2022, Aurora, CO))
Year
2022

Post-Hoc Analysis of Efficacy and Safety in the SWOG S0777 Trial Stratified By Age

Authors
B Durie;A Lam;M Ngo;H Pei;E Ammann
Journal / Conference
Blood. 2022;140 (supplement 1):10009-10010; ASH Annual Meeting (Dec 10-12, 2022, New Orleans, LA)
Year
2022
Research Committee(s)
Myeloma
Study Number(s)
S0777

Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival

Authors
RA Cannioto;A Hutson;S Dighe;W McCann;S McCann;G Zirpoli;W Barlow;KM Kelly;CA DeNysschen;DL Hershman;JM Unger;HCF Moore;JA Stewart;C Isaacs;T Hobday;M Salim;GN Hortobagyi;J Gralow;K Albain;GT Budd;C Ambrosone
Journal / Conference
Journal of the National Cancer Institute Jan 4;113(1):54-63
Year
2021
Research Committee(s)
Breast
PMID
PMID32239145
Study Number(s)
S0221

The effect of metformin vs placebo on sex hormones in CCTG MA.32

Authors
I Pimentel;B Chen;A Lohman;M Ennis;J Ligibel;L Shepherd;D Hershman;T Whelan;V Stambolic;I Mayer;T Hobday;J Lemieux;A Thompson;P Rastogi;K Gelmon;D Rea;M Rabaglio;S Ellard;M Mates;P Bedard;L Petre;T Vandenberg;R Dowling;W Parulekar;P Goodwin
Journal / Conference
Journal of the National Cancer Institute Feb 1;113(2):192-198. doi: 10.1093/jnci/djaa082
Year
2021
Research Committee(s)
Breast
PMID
PMID32497219
PMC
PMC7850529

Mental Component score (MCS) from Health-related Quality of Life Predicts Incidence of Dementia in U.S. Males

Authors
X Ding;E Abner;F Schmitt;J Crowley;P Goodman;R Kryscio
Journal / Conference
Journal of Prevention of Alzheimer's Disease 8(2):169-174
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID33569563
PMC
PMC8162937
Study Number(s)
S0000A

Improvement initiative to develop and implement a tool for detecting drug-drug interactions during oncology clinical trial enrollment eligibility screening

Authors
LA Marcath;T Coe;F Shakeel;E Reynolds;M Bayuk;S Haas;BG Redman;S-F Wong;DL Hertz
Journal / Conference
Journal of Patient Safety Jan 1;17(1):e28-e34. doi: 10.1097/PTS.0000000000000772; Sep 29. doi: 10.1097/PTS.0000000000000772. Online ahead of print
Year
2021
Research Committee(s)
Multiple sites
PMID
PMID33003175
PMC
PMC7775319

Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial

Authors
K Albain;R Gray;D Makower;A Faghih;DF Hayes;C Geyer;E Dees;M Goetz;J Olson;T Lively;S Bavde;T Saphner;L Wagner;T Whelan;M Ellis;S Paik;W Wood;P Ravdin;M Keane;H Gomez;P Reddy;T Goggins;I Mayer;A Brufsky;D Toppmeyer;V Kaklamani;J Berenberg;J Abrams;G Sledge;J Sparano
Journal / Conference
Journal of the National Cancer Institute Apr 6;113(4):390-399
Year
2021
Research Committee(s)
Breast
PMID
PMID32986828
PMC
PMC8599918